Back to User profile » Dr Po-Liang Lu

Papers published by Dr Po-Liang Lu:

Clinical Trial Report

Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Lai CC, Chen YS, Lee NY, Tang HJ, Lee SSJ, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR

Infection and Drug Resistance 2019, 12:627-640

Published Date: 14 March 2019

Original Research

In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Jean SS, Lu MC, Shi ZY, Tseng SH, Wu TS, Lu PL, Shao PL, Ko WC, Wang FD, Hsueh PR

Infection and Drug Resistance 2018, 11:1983-1992

Published Date: 26 October 2018